NCT01991821View on ClinicalTrials.gov

European Phase III Study of APD421 in PONV

PHASE3CompletedINTERVENTIONAL

Enrollment

368

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

PONV

Interventions

DRUG

APD421

DRUG

Placebo

Trial Locations (2)

Unknown

CHU de Hautepierre, Strasbourg

University Hospitals of Würzburg, Würzburg

Sponsors

Lead Sponsor

Acacia Pharma Ltd

All Listed Sponsors

lead

Acacia Pharma Ltd

INDUSTRY